VR Adviser as of March 31, 2021
Portfolio Holdings for VR Adviser
VR Adviser holds 28 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Instil Bio | 18.7 | $172M | 6.9M | 25.08 | |
| Constellation Pharmceticls I | 10.2 | $94M | 4.0M | 23.39 | |
| Aclaris Therapeutics (ACRS) | 10.2 | $94M | 3.7M | 25.20 | |
| Olema Pharmaceuticals (OLMA) | 5.5 | $51M | 1.5M | 33.18 | |
| Altimmune (ALT) | 5.4 | $50M | 3.5M | 14.13 | |
| Cullinan Oncology (CGEM) | 5.3 | $49M | 1.2M | 41.67 | |
| Kinnate Biopharma | 5.0 | $46M | 1.5M | 31.16 | |
| Trillium Therapeutics, Inc. Cmn | 4.7 | $43M | 4.0M | 10.74 | |
| Marinus Pharmaceuticals (MRNS) | 4.4 | $41M | 2.6M | 15.48 | |
| Vistagen Therapeutics | 3.8 | $35M | 16M | 2.13 | |
| Athira Pharma (ATHA) | 3.4 | $31M | 1.7M | 18.40 | |
| Relmada Therapeutics (RLMD) | 3.3 | $30M | 853k | 35.21 | |
| Celldex Therapeutics (CLDX) | 2.8 | $26M | 1.2M | 20.60 | |
| Pharvaris N V (PHVS) | 2.7 | $25M | 903k | 28.06 | |
| Keros Therapeutics (KROS) | 2.5 | $23M | 372k | 61.55 | |
| Essa Pharma (EPIX) | 2.0 | $18M | 626k | 29.05 | |
| Kura Oncology (KURA) | 1.8 | $16M | 575k | 28.27 | |
| Syndax Pharmaceuticals (SNDX) | 1.4 | $13M | 592k | 22.36 | |
| Adicet Bio (ACET) | 1.4 | $13M | 1.0M | 13.08 | |
| Aptose Biosciences | 1.0 | $9.6M | 1.6M | 5.97 | |
| Cogent Biosciences (COGT) | 1.0 | $9.6M | 1.1M | 8.78 | |
| Aligos Therapeutics (ALGS) | 1.0 | $9.3M | 408k | 22.74 | |
| Eyepoint Pharmaceuticals (EYPT) | 0.8 | $7.1M | 700k | 10.16 | |
| Bctg Acquisition Corp | 0.6 | $5.6M | 500k | 11.12 | |
| Metacrine Ord | 0.5 | $4.2M | 680k | 6.20 | |
| Silverback Therapeutics (SPRY) | 0.4 | $3.7M | 85k | 43.64 | |
| Taysha Gene Therapies (TSHA) | 0.3 | $2.4M | 121k | 20.30 | |
| Miragen Therapeutics (VRDN) | 0.0 | $326k | 20k | 16.72 |
